BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10732416)

  • 1. [My approach to the management of a type I diabetic treated with short-acting insulin analogue].
    Colombel A; Charbonnel B
    Journ Annu Diabetol Hotel Dieu; 1999; ():165-77. PubMed ID: 10732416
    [No Abstract]   [Full Text] [Related]  

  • 2. An update on the long-acting insulin analogue glargine.
    Thisted H; Johnsen SP; Rungby J
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin detemir: a new basal insulin analogue.
    Soran H; Younis N
    Diabetes Obes Metab; 2006 Jan; 8(1):26-30. PubMed ID: 16367879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; GarcĂ­a-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-acting insulin analogs: progressing slowly].
    Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1668-9. PubMed ID: 15453117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocturnal hypoglycemia in patients with insulin-treated diabetes.
    Yale JF
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S41-6. PubMed ID: 15315870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-acting insulin analogs: progressing slowly].
    Geelhoed-Duijvestijn PH
    Ned Tijdschr Geneeskd; 2004 Nov; 148(45):2248; author reply 2248-9. PubMed ID: 15568634
    [No Abstract]   [Full Text] [Related]  

  • 10. [New insulin with uniform action. Hazards of blood sugar variations minimized].
    MMW Fortschr Med; 2003 Oct; 145(40):55. PubMed ID: 14603609
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
    Ross SA; Zinman B; Campos RV; Strack T;
    Clin Invest Med; 2001 Dec; 24(6):292-8. PubMed ID: 11767232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump.
    Catargi B; Breilh D; Roger P; Tabarin A
    Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of hypoglycemic brittle diabetes with peripheral edema successfully managed by conversion from insulin lispro to insulin aspart.
    Tone A; Shikata K; Nakagawa K; Hashimoto M; Makino H
    Diabetes Res Clin Pract; 2008 Sep; 81(3):e15-6. PubMed ID: 18676048
    [No Abstract]   [Full Text] [Related]  

  • 14. Postprandial rather than preprandial glucose levels should be used for adjustment of rapid-acting insulins.
    Bell DS; Ovalle F; Shadmany S
    Endocr Pract; 2000; 6(6):477-8. PubMed ID: 11155223
    [No Abstract]   [Full Text] [Related]  

  • 15. Intensive insulin treatment in diabetic children.
    Ludvigsson J; Bolli GB
    Diabetes Nutr Metab; 2001 Oct; 14(5):292-304. PubMed ID: 11806471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin aspart: a review.
    Owens D; Vora J
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [My quality of life has increased with Lantus].
    Euler H
    Lakartidningen; 2004 Sep; 101(39):3015; discussion 3016. PubMed ID: 15493645
    [No Abstract]   [Full Text] [Related]  

  • 18. Lispro insulin in type 1 diabetic patients on a Mediterranean or normal diet: a randomized, cross-over comparative study with regular insulin.
    Provenzano C; Vero R; Oliva A; Leto G; Puccio L; Vecci E; Mattioli PL; Di Mario U
    Diabetes Nutr Metab; 2001 Jun; 14(3):133-9. PubMed ID: 11476360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin analogues--patient preference may drive prescribing.
    Thompson C
    Ir Med J; 1998; 91(1):16-7. PubMed ID: 9563247
    [No Abstract]   [Full Text] [Related]  

  • 20. Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus.
    Admon G; Weinstein Y; Falk B; Weintrob N; Benzaquen H; Ofan R; Fayman G; Zigel L; Constantini N; Phillip M
    Pediatrics; 2005 Sep; 116(3):e348-55. PubMed ID: 16140677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.